SkinHealth Systems Inc. Financial Ratios
SKIN|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-193.3%
Profit Margin
-25.2%
Net Income / Revenue
Asset Turnover
0.80
Revenue / Total Assets
Equity Multiplier
9.65
Total Assets / Equity
Composite: -193.3% (reported: -193.3%)
Profitability
Liquidity
Current Ratio
1.66
Quick Ratio
1.40
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.80
Inventory Turnover
5.06
Days Sales Outstanding
20 days
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-20.6%
-42.6pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.